Skip to content

A clinical study to evaluate the effects of the Linablue tablet on skin function

A clinical study to evaluate the effects of the Linablue tablet on skin function - A clinical study to evaluate the effects of the Linablue tablet on skin function

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000035205
Enrollment
96
Registered
2020-03-31
Start date
2018-12-15
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers

Interventions

Intake of the test food (tablets that contain Linablue ) for 8 weeks Intake of the placebo (tablets that don&#39
t contain Linablue) for 8 weeks

Sponsors

Soiken Inc.
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1)Healthy females whose age of 20 years or more and less than 65 years 2)Subjects who experience dry skin 3)Subjects having a briefing of the content of the present study, fully understanding and agreeing to its objective and being able to personally sign a written informed consent

Exclusion criteria

Exclusion criteria: 1)Subjects who are dermatological patients 2)Subjects receiving a medical treatment for serious renal, hepatic, cardio-vascular, respiratory, endocrine or metabolic disorders or having a medical history of these disorders 3)Subjects having the possibility of developing allergic symptoms by the test food 4)Subjects taking regularly foods for specified health uses, foods with function claims labeled, medicines or quasi-drugs having the effects on skin function 5)Subjects who are pregnant or lactating, or intending to become pregnant during the study 6)Subjects who took part in another clinical study within 3 months prior to the start of the present study or who are currently taking part in another clinical study 7)Subjects deemed unsuitable by the investigator

Design outcomes

Primary

MeasureTime frame
Transepidermal Water Loss (TEWL)

Secondary

MeasureTime frame
Hydration level of the skin surface Elasticity of the upper skin layer Skin replica analysis (wrinkles and texture) Microscopic analysis by the dermatologist (wrinkles and spots)

Countries

Japan

Contacts

Public ContactTomohiro Sugino

Soiken Inc. R&D Division

sugino@soiken.com06-6871-8888

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026